Xilis, Inc. is a biotech company focused on transforming cancer treatment through innovative technologies that enable personalized medicine. By leveraging its proprietary MicroOrganoSphere™ technology, Xilis offers tailored therapeutic solutions that match cancer patients with the most effective treatments based on their individual tumor biology.
Company Values
Xilis stands out by creating microscale tumor models that closely mimic patient tumors, allowing for highly accurate predictions of treatment responses.